Bisphenol A found in food and beverage packaging is an<unk>  showing up in the bodies of about 95% of the human population.<unk> s are foreign chemical compounds that are hypothesised to disrupt normal development and balance of lipid metabolism, which in some cases, can lead to obesity.<unk> s may be functionally defined as chemicals that inappropriately alter lipid homeostasis and fat storage, change metabolic setpoints, disrupt energy balance or modify the regulation of appetite and satiety to promote fat accumulation and obesity. There are many different proposed mechanisms through which<unk> s can interfere with the body's adipose tissue biology. These mechanisms include alterations in the action of metabolic sensors; dysregulation of sex steroid synthesis, action or breakdown; changes in the central integration of energy balance including the regulation of appetite and satiety; and reprogramming of metabolic setpoints. Some of these proposed pathways include inappropriate modulation of nuclear receptor function which therefore allows the compounds to be classified as endocrine disrupting chemicals that act to mimic hormones in the body, altering the normal homeostasis maintained by the endocrine system.<unk> s have been detected in the body both as a result of intentional administration of<unk> ic chemicals in the form of pharmaceutical drugs such as diethylstilbestrol, selective serotonin reuptake inhibitors, and thiazolidinedione and as a result of unintentional exposure to environmental<unk> s such as tributyltin, bisphenol A, diethylhexylphthalate, and perfluorooctanoate. The term<unk>  was coined in 2006 by Felix Grün and Bruce Blumberg of the University of California, Irvine. The topic of this proposed class of chemical compounds and how to counteract their effects is explored at length in the book The New American Diet.
Obesogen
Eoxin
Squalene
Asthmagen
Beta-Zearalenol
1,4-Dioxin
Nicosan
Toxicophore